Kbc Group Nv Bristol Myers Squibb CO Transaction History

Kbc Group Nv

$33.1 Billion
Q2 2024

A detailed history of Kbc Group Nv transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kbc Group Nv holds 5,616,327 shares of BMY stock, worth $299 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

5,616,327

Previous 5,295,590 6.06%

Holding current value

$299 Million

Previous $287 Million 18.78%

% of portfolio

0.7%

Previous 0.91%

43 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$40.25 - $52.99 $12.9 Million - $17 Million	320,737 Added 6.06%	5,616,327 $233 Million
Q1 2024 May 08, 2024	BUY	$47.98 - $54.4 $117 Million - $133 Million	2,448,190 Added 85.98%	5,295,590 $287 Million
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $34.7 Million - $41.3 Million	714,760 Added 33.52%	2,847,400 $146 Million
Q3 2023 Feb 15, 2024	SELL	$57.89 - $64.73 $39.2 Million - $43.8 Million	-676,743 Reduced 31.37%	1,480,249 $85.9 Million
Q2 2023 Feb 15, 2024	SELL	$63.71 - $70.74 $42.6 Million - $47.3 Million	-668,904 Reduced 23.67%	2,156,992 $138 Million
Q2 2023 Jul 28, 2023	BUY	$63.71 - $70.74 $41.3 Million - $45.8 Million	648,053 Added 43.65%	2,132,640 $136 Million
Q1 2023 Feb 14, 2024	SELL	$65.71 - $74.53 $19.3 Million - $21.9 Million	-293,580 Reduced 16.37%	1,500,268 $104 Million
Q1 2023 May 04, 2023	SELL	$65.71 - $74.53 $87.9 Million - $99.7 Million	-1,338,039 Reduced 47.4%	1,484,587 $103 Million
Q4 2022 Feb 14, 2024	SELL	$68.48 - $81.09 $89.5 Million - $106 Million	-1,307,278 Reduced 42.15%	1,793,848 $129 Million
Q3 2022 Feb 15, 2024	SELL	$0.13 - $76.84 $2,795 - $1.65 Million	-21,504 Reduced 0.76%	2,825,896 $201 Million
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $34,102 - $20.2 Million	-262,330 Reduced 8.5%	2,822,626 $201 Million
Q2 2022 Feb 14, 2024	BUY	$72.62 - $79.98 $5.78 Million - $6.37 Million	79,629 Added 2.64%	3,101,126 $239 Million
Q2 2022 Jul 26, 2022	BUY	$72.62 - $79.98 $4.61 Million - $5.08 Million	63,459 Added 2.1%	3,084,956 $238 Million
Q1 2022 Feb 14, 2024	BUY	$61.48 - $73.72 $16.8 Million - $20.1 Million	272,853 Added 9.93%	3,021,497 $221 Million
Q1 2022 May 06, 2022	BUY	$61.48 - $73.72 $16.8 Million - $20.1 Million	272,853 Added 9.93%	3,021,497 $221 Million
Q4 2021 Feb 14, 2024	SELL	$53.63 - $62.52 $5.3 Million - $6.17 Million	-98,756 Reduced 3.47%	2,748,644 $171 Million
Q4 2021 Feb 03, 2022	BUY	$53.63 - $62.52 $1.76 Million - $2.05 Million	32,810 Added 1.21%	2,748,644 $171 Million
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $10.1 Million - $11.9 Million	170,981 Added 6.72%	2,715,834 $161 Million
Q2 2021 Aug 11, 2021	BUY	$61.91 - $67.42 $15.2 Million - $16.6 Million	246,049 Added 10.7%	2,544,853 $170 Million
Q1 2021 Apr 26, 2021	BUY	$59.34 - $66.74 $6.46 Million - $7.27 Million	108,909 Added 4.97%	2,298,804 $145 Million
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $28 Million - $31.7 Million	484,443 Added 28.41%	2,189,895 $136 Million
Q3 2020 Oct 28, 2020	BUY	$57.43 - $63.64 $10.1 Million - $11.2 Million	176,568 Added 11.55%	1,705,452 $103 Million
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $37.6 Million - $44 Million	685,861 Added 81.36%	1,528,884 $89.9 Million
Q1 2020 May 04, 2020	SELL	$46.4 - $67.43 $4.65 Million - $6.76 Million	-100,257 Reduced 10.63%	843,023 $47 Million
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $3.41 Million - $4.44 Million	69,199 Added 7.92%	943,280 $60.5 Million
Q3 2019 Nov 07, 2019	BUY	$42.77 - $50.71 $37.3 Million - $44.2 Million	872,055 Added 43043.19%	874,081 $44.3 Million
Q2 2019 Dec 03, 2019	SELL	$44.62 - $49.34 $37.6 Million - $41.6 Million	-843,682 Reduced 99.76%	2,026 $92,000
Q2 2019 Jul 30, 2019	BUY	$44.62 - $49.34 $37.6 Million - $41.6 Million	843,682 Added 41642.74%	845,708 $0
Q1 2019 Dec 03, 2019	SELL	$45.12 - $53.8 $33.2 Million - $39.5 Million	-734,718 Reduced 99.73%	2,026 $97,000
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $33.2 Million - $39.5 Million	734,718 Added 36264.46%	736,744 $0
Q4 2018 Dec 03, 2019	SELL	$48.76 - $63.23 $20.2 Million - $26.2 Million	-413,822 Reduced 99.51%	2,026 $105,000
Q4 2018 Jan 31, 2019	BUY	$48.76 - $63.23 $20.2 Million - $26.2 Million	413,822 Added 20425.57%	415,848 $21.6 Million
Q3 2018 Dec 03, 2019	SELL	$55.19 - $62.25 $22 Million - $24.8 Million	-398,357 Reduced 99.49%	2,026 $126,000
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $22 Million - $24.8 Million	398,357 Added 19662.24%	400,383 $0
Q2 2018 Dec 03, 2019	SELL	$50.53 - $62.98 $18.1 Million - $22.5 Million	-357,791 Reduced 99.44%	2,026 $112,000
Q2 2018 Aug 03, 2018	BUY	$50.53 - $62.98 $18.1 Million - $22.5 Million	357,791 Added 17659.97%	359,817 $0
Q1 2018 Dec 03, 2019	SELL	$59.92 - $68.98 $22.1 Million - $25.5 Million	-369,199 Reduced 99.45%	2,026 $128,000
Q1 2018 May 09, 2018	BUY	$59.92 - $68.98 $22.1 Million - $25.5 Million	369,199 Added 18223.05%	371,225 $0
Q4 2017 Dec 03, 2019	SELL	$59.94 - $65.35 $19 Million - $20.7 Million	-317,429 Reduced 99.37%	2,026 $124,000
Q4 2017 Feb 07, 2018	BUY	$59.94 - $65.35 $19 Million - $20.7 Million	317,429 Added 15667.77%	319,455 $0
Q3 2017 Dec 03, 2019	SELL	$55.23 - $63.74 $25.9 Million - $29.9 Million	-468,716 Reduced 99.57%	2,026 $129,000
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $25.9 Million - $29.9 Million	468,716 Added 23135.04%	470,742 $0
Q2 2017 Dec 03, 2019	BUY	N/A	2,026	2,026 $113,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account